Hyaluronic acid ion-pairing nanoparticles for targeted tumor therapy

HA-NPs and HA-LPs have been developed to be selectively taken up by CD44+ tumor cells, which greatly improved antitumor efficacy and reduced systemic adverse effects in treating CD44+ cancer.301